Author:
Velasco María,Salvador Luis,Juárez Carmelo,Antoñanzas Fernando
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference41 articles.
1. Murray CJL, López AD. The Global burden of disease: a comprehensive assessment of mortality and disability from disease,injures and risk factors in 1990 and projected to 2020, vol1. WHO Cambridge, Harvard University Press, 1996.
2. Travé Rodríguez AL, Reneses Sacristán A. Manejo de los fármacos en el tratamiento de la depresión. Inf Ter Nac Salud 2002; 26: 1–8.
3. Gabarron Hortal E, Vidal Royo JM, Haro Abad JM, Boix Soriano I, Jover Blanca A, Arenas Prat M. Prevalencia and detection of depressive disorders in primary care. Aten Primaria 2002 Apr 15; 29 (6): 336–7.
4. Ayuso Mateos JL, Vázquez Barquero JL, Dowrick C, Lehtinen V, Dalgard OS, Casey P, Wilkinson C, Lasa L, Page H, Dunn G, Wilkinson G, ODIN Group. Depressive disorders in Europe: prevalence figures from the ODIN Study. Br J Psychiatry 2001 Oct; 179: 308–16.
5. Andrews G. Should depression be managed as a chronic disease? BMJ 2001; 322: 419–21.